Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome.

Sookoian S, Pirola CJ.

World J Gastroenterol. 2012 Aug 7;18(29):3775-81. doi: 10.3748/wjg.v18.i29.3775. Review.

2.

Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level.

Sookoian S, Castaño GO, Scian R, Fernández Gianotti T, Dopazo H, Rohr C, Gaj G, San Martino J, Sevic I, Flichman D, Pirola CJ.

Am J Clin Nutr. 2016 Feb;103(2):422-34. doi: 10.3945/ajcn.115.118695. Epub 2016 Jan 20.

PMID:
26791191
4.

Metabolite profiling identifies pathways associated with metabolic risk in humans.

Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, Palma MJ, Roberts LD, Dejam A, Souza AL, Deik AA, Magnusson M, Fox CS, O'Donnell CJ, Vasan RS, Melander O, Clish CB, Gerszten RE, Wang TJ.

Circulation. 2012 May 8;125(18):2222-31. doi: 10.1161/CIRCULATIONAHA.111.067827. Epub 2012 Apr 11.

5.

Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.

Sookoian S, Pirola CJ.

World J Gastroenterol. 2015 Jan 21;21(3):711-25. doi: 10.3748/wjg.v21.i3.711. Review.

6.

Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, Dall'Aglio E, Dalle Grave R, Morpurgo PS, Tomasi F, Vitacolonna E.

J Endocrinol Invest. 2005 Apr;28(4):333-9.

PMID:
15966506
7.

Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.

Jung KY, Cho SY, Kim HJ, Kim SB, Song IH.

J Clin Gastroenterol. 2014 Nov-Dec;48(10):883-8. doi: 10.1097/MCG.0000000000000065.

PMID:
24440936
8.

[Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease].

Liu M, Yan HM, Gao X, Gao J.

Zhonghua Yi Xue Za Zhi. 2007 Jan 23;87(4):253-5. Chinese.

PMID:
17425870
9.

Short-term metabolic fate of [13N]ammonia in rat liver in vivo.

Cooper AJ, Nieves E, Coleman AE, Filc-DeRicco S, Gelbard AS.

J Biol Chem. 1987 Jan 25;262(3):1073-80.

10.

Prevalence and associated metabolic factors of fatty liver disease in the elderly.

Wang Z, Xu M, Peng J, Jiang L, Hu Z, Wang H, Zhou S, Zhou R, Hultström M, Lai EY.

Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27.

PMID:
23721951
11.

Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.

Lee YS, Kek BL, Poh LK, Saw SM, Loke KY.

J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):172-8. doi: 10.1097/MPG.0b013e318162a0e5.

PMID:
18664869
12.

Decreased plasma glutamate in early phases of septic shock with acute liver dysfunction is an independent predictor of survival.

Poeze M, Luiking YC, Breedveld P, Manders S, Deutz NE.

Clin Nutr. 2008 Aug;27(4):523-30. doi: 10.1016/j.clnu.2008.04.006. Epub 2008 Jun 13.

PMID:
18554754
13.

Chronic metabolic effects of ammonia in mouse brain.

Sadasivudu B, Indira Rao T, Radhakrishna Murthy C.

Arch Int Physiol Biochim. 1979 Dec;87(5):871-85.

PMID:
94819
14.

UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity.

Labruna G, Pasanisi F, Nardelli C, Tarantino G, Vitale DF, Bracale R, Finelli C, Genua MP, Contaldo F, Sacchetti L.

J Endocrinol Invest. 2009 Jun;32(6):525-9. doi: 10.3275/6108. Epub 2009 Mar 26.

PMID:
19474520
15.

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.

Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM.

Diabetes. 2005 Nov;54(11):3140-7.

16.

Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus.

Zhang Y, Lu X, Hong J, Chao M, Gu W, Wang W, Ning G.

Endocrine. 2010 Oct;38(2):181-7. doi: 10.1007/s12020-010-9369-6. Epub 2010 Oct 23.

PMID:
20972737
17.

Non-alcoholic steatohepatitis with normal aminotransferase values.

Uslusoy HS, Nak SG, Gülten M, Biyikli Z.

World J Gastroenterol. 2009 Apr 21;15(15):1863-8.

18.

Role of aminotransferases in glutamate metabolism of human erythrocytes.

Ellinger JJ, Lewis IA, Markley JL.

J Biomol NMR. 2011 Apr;49(3-4):221-9. doi: 10.1007/s10858-011-9481-9. Epub 2011 Mar 6.

19.

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.

Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A.

Metabolism. 2013 Mar;62(3):352-60. doi: 10.1016/j.metabol.2012.08.005. Epub 2012 Sep 19.

PMID:
22999011
20.

Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease.

Ioannou GN, Weiss NS, Boyko EJ, Kahn SE, Lee SP.

Gastroenterology. 2005 Mar;128(3):627-35.

PMID:
15810122
Items per page

Supplemental Content

Write to the Help Desk